top of page
Akthelia News Desk
Oct 17, 2024
Akthelia Pharmaceuticals Awarded RANNIS Grant to Accelerate Development of Gastrimod® (AKT-011) for Chemotherapy-Induced FN
Akthelia Pharmaceuticals is pleased to announce it has been awarded a two-year $350,000 research grant by RANNIS
bottom of page